,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,data_processing,platform_id,contact_name,contact_email,contact_phone,contact_laboratory,contact_department,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,supplementary_file,supplementary_file.1,data_row_count,age at surgery:ch1,final.pat.stage:ch1,gender:ch1,had_adjuvant_chemo:ch1,histology:ch1,overall_survival_months,Event
GSM1032881,human lung cancer sample 250-T,GSM1032881,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 33.6,survival status: D,age at surgery: 63.8,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),250-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032881/suppl/GSM1032881_5058818004_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032881/suppl/GSM1032881_5058818004_A_2.txt.gz,48803,63.8,IB,M,FALSE,Adenocarcinoma,33.6,D
GSM1032882,human lung cancer sample 259-T,GSM1032882,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 33.6,survival status: D,age at surgery: 60.4,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),259-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032882/suppl/GSM1032882_5067386010_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032882/suppl/GSM1032882_5067386010_F_2.txt.gz,48803,60.4,IB,F,FALSE,Adenocarcinoma,33.6,D
GSM1032884,human lung cancer sample 296-T,GSM1032884,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 106.8,survival status: D,age at surgery: 67.6,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),296-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032884/suppl/GSM1032884_5058818049_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032884/suppl/GSM1032884_5058818049_F_2.txt.gz,48803,67.6,IIIB,M,FALSE,Adenocarcinoma,106.8,D
GSM1032885,human lung cancer sample 309-T,GSM1032885,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 132,survival status: A,age at surgery: 68.5,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),309-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032885/suppl/GSM1032885_5058818022_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032885/suppl/GSM1032885_5058818022_F_2.txt.gz,48803,68.5,IA,F,FALSE,Adenocarcinoma,132,A
GSM1032886,human lung cancer sample 346-T,GSM1032886,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 117.6,survival status: A,age at surgery: 53.5,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),346-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032886/suppl/GSM1032886_5051018065_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032886/suppl/GSM1032886_5051018065_F_2.txt.gz,48803,53.5,IB,F,FALSE,Adenocarcinoma,117.6,A
GSM1032887,human lung cancer sample 363-T,GSM1032887,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 88.8,survival status: D,age at surgery: 78.4,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),363-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032887/suppl/GSM1032887_5059335015_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032887/suppl/GSM1032887_5059335015_A_2.txt.gz,48803,78.4,IB,M,FALSE,Adenocarcinoma,88.8,D
GSM1032889,human lung cancer sample 386-T,GSM1032889,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 127.2,survival status: A,age at surgery: 58.6,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),386-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032889/suppl/GSM1032889_5058818024_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032889/suppl/GSM1032889_5058818024_B_2.txt.gz,48803,58.6,IA,F,FALSE,Adenocarcinoma,127.2,A
GSM1032891,human lung cancer sample 399-T,GSM1032891,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 129.6,survival status: A,age at surgery: 55.7,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),399-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032891/suppl/GSM1032891_5059335007_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032891/suppl/GSM1032891_5059335007_F_2.txt.gz,48803,55.7,IB,M,FALSE,Adenocarcinoma,129.6,A
GSM1032892,human lung cancer sample 404-T,GSM1032892,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 127.2,survival status: A,age at surgery: 51.4,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),404-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032892/suppl/GSM1032892_5058818024_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032892/suppl/GSM1032892_5058818024_C_2.txt.gz,48803,51.4,IA,M,FALSE,Adenocarcinoma,127.2,A
GSM1032893,human lung cancer sample 416-T,GSM1032893,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 14.4,survival status: D,age at surgery: 69.8,gender: F,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),416-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032893/suppl/GSM1032893_5058818049_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032893/suppl/GSM1032893_5058818049_A_2.txt.gz,48803,69.8,IIIA,F,FALSE,Adenocarcinoma,14.4,D
GSM1032894,human lung cancer sample 426-T,GSM1032894,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 91.2,survival status: A,age at surgery: 46.9,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),426-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032894/suppl/GSM1032894_5067386029_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032894/suppl/GSM1032894_5067386029_E_2.txt.gz,48803,46.9,IB,M,FALSE,Adenocarcinoma,91.2,A
GSM1032895,human lung cancer sample 439-T,GSM1032895,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 27.6,survival status: D,age at surgery: 70.8,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),439-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032895/suppl/GSM1032895_5058818024_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032895/suppl/GSM1032895_5058818024_D_2.txt.gz,48803,70.8,IA,M,FALSE,Adenocarcinoma,27.6,D
GSM1032898,human lung cancer sample 475-T,GSM1032898,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 122.4,survival status: A,age at surgery: 61.4,gender: F,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),475-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032898/suppl/GSM1032898_5067319027_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032898/suppl/GSM1032898_5067319027_C_2.txt.gz,48803,61.4,IIB,F,FALSE,Adenocarcinoma,122.4,A
GSM1032899,human lung cancer sample 482-T,GSM1032899,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 7.2,survival status: A,age at surgery: 47.4,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),482-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032899/suppl/GSM1032899_5059335014_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032899/suppl/GSM1032899_5059335014_D_2.txt.gz,48803,47.4,IB,M,FALSE,Adenocarcinoma,7.2,A
GSM1032901,human lung cancer sample 495-T,GSM1032901,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 34.8,survival status: D,age at surgery: 73.5,gender: F,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),495-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032901/suppl/GSM1032901_5059335016_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032901/suppl/GSM1032901_5059335016_B_2.txt.gz,48803,73.5,IIIA,F,FALSE,Adenocarcinoma,34.8,D
GSM1032902,human lung cancer sample 497-T,GSM1032902,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 38.4,survival status: D,age at surgery: 64.7,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),497-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032902/suppl/GSM1032902_5058818040_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032902/suppl/GSM1032902_5058818040_F_2.txt.gz,48803,64.7,IIB,M,FALSE,Adenocarcinoma,38.4,D
GSM1032903,human lung cancer sample 534-T,GSM1032903,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 14.4,survival status: D,age at surgery: 59.8,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),534-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032903/suppl/GSM1032903_5058818005_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032903/suppl/GSM1032903_5058818005_C_2.txt.gz,48803,59.8,IB,F,FALSE,Adenocarcinoma,14.4,D
GSM1032904,human lung cancer sample 535-T,GSM1032904,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 118.8,survival status: A,age at surgery: 60.3,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),535-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032904/suppl/GSM1032904_5058818004_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032904/suppl/GSM1032904_5058818004_D_2.txt.gz,48803,60.3,IB,M,FALSE,Adenocarcinoma,118.8,A
GSM1032905,human lung cancer sample 545-T,GSM1032905,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 21.6,survival status: D,age at surgery: 72.6,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),545-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032905/suppl/GSM1032905_5067386029_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032905/suppl/GSM1032905_5067386029_C_2.txt.gz,48803,72.6,IB,M,FALSE,Adenocarcinoma,21.6,D
GSM1032906,human lung cancer sample 566-T,GSM1032906,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 31.2,survival status: D,age at surgery: 83.4,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),566-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032906/suppl/GSM1032906_5067319027_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032906/suppl/GSM1032906_5067319027_A_2.txt.gz,48803,83.4,IB,M,FALSE,Adenocarcinoma,31.2,D
GSM1032907,human lung cancer sample 568-T,GSM1032907,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 50.4,survival status: D,age at surgery: 75.9,gender: M,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),568-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032907/suppl/GSM1032907_5058818049_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032907/suppl/GSM1032907_5058818049_C_2.txt.gz,48803,75.9,IIIA,M,FALSE,Adenocarcinoma,50.4,D
GSM1032909,human lung cancer sample 589-T2,GSM1032909,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 96,survival status: D,age at surgery: 76.5,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),589-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032909/suppl/GSM1032909_5059335009_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032909/suppl/GSM1032909_5059335009_D_2.txt.gz,48803,76.5,IB,M,FALSE,Adenocarcinoma,96,D
GSM1032910,human lung cancer sample 590-T,GSM1032910,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 106.8,survival status: A,age at surgery: 71.9,gender: F,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),590-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032910/suppl/GSM1032910_5059335024_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032910/suppl/GSM1032910_5059335024_B_2.txt.gz,48803,71.9,IIA,F,FALSE,Adenocarcinoma,106.8,A
GSM1032911,human lung cancer sample 593-T,GSM1032911,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 120,survival status: A,age at surgery: 63.5,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),593-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032911/suppl/GSM1032911_5059335018_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032911/suppl/GSM1032911_5059335018_F_2.txt.gz,48803,63.5,IIB,M,FALSE,Adenocarcinoma,120,A
GSM1032913,human lung cancer sample 619-T2,GSM1032913,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 82.8,survival status: D,age at surgery: 80.0,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),619-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032913/suppl/GSM1032913_5067386010_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032913/suppl/GSM1032913_5067386010_C_2.txt.gz,48803,80,IIB,M,FALSE,Adenocarcinoma,82.8,D
GSM1032914,human lung cancer sample 630-T,GSM1032914,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 114,survival status: A,age at surgery: 64.8,gender: F,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),630-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032914/suppl/GSM1032914_5058818045_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032914/suppl/GSM1032914_5058818045_C_2.txt.gz,48803,64.8,IIB,F,FALSE,Adenocarcinoma,114,A
GSM1032915,human lung cancer sample 650-T2,GSM1032915,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 115.2,survival status: A,age at surgery: 59.4,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),650-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032915/suppl/GSM1032915_5059335028_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032915/suppl/GSM1032915_5059335028_C_2.txt.gz,48803,59.4,IB,M,FALSE,Adenocarcinoma,115.2,A
GSM1032919,human lung cancer sample 697-T,GSM1032919,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 12,survival status: D,age at surgery: 72.2,gender: F,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),697-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032919/suppl/GSM1032919_5059335013_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032919/suppl/GSM1032919_5059335013_F_2.txt.gz,48803,72.2,IIB,F,FALSE,Adenocarcinoma,12,D
GSM1032920,human lung cancer sample 717-T,GSM1032920,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 62.4,survival status: D,age at surgery: 50.1,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),717-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032920/suppl/GSM1032920_5059335013_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032920/suppl/GSM1032920_5059335013_B_2.txt.gz,48803,50.1,IB,M,FALSE,Adenocarcinoma,62.4,D
GSM1032925,human lung cancer sample 764-T,GSM1032925,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 88.8,survival status: A,age at surgery: 58.2,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),764-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032925/suppl/GSM1032925_5067386010_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032925/suppl/GSM1032925_5067386010_B_2.txt.gz,48803,58.2,IB,F,FALSE,Adenocarcinoma,88.8,A
GSM1032927,human lung cancer sample 792-T,GSM1032927,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 80.4,survival status: D,age at surgery: 66.9,gender: M,final.pat.stage: unknown,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),792-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032927/suppl/GSM1032927_5058818024_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032927/suppl/GSM1032927_5058818024_F_2.txt.gz,48803,66.9,unknown,M,FALSE,Adenocarcinoma,80.4,D
GSM1032929,human lung cancer sample 847-T1,GSM1032929,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 0,survival status: D,age at surgery: 60.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),847-T1,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032929/suppl/GSM1032929_5051018065_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032929/suppl/GSM1032929_5051018065_D_2.txt.gz,48803,60.3,IB,F,FALSE,Adenocarcinoma,0,D
GSM1032930,human lung cancer sample 896-T1,GSM1032930,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 84,survival status: A,age at surgery: 49.3,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),896-T1,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032930/suppl/GSM1032930_5067386004_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032930/suppl/GSM1032930_5067386004_A_2.txt.gz,48803,49.3,IA,F,FALSE,Adenocarcinoma,84,A
GSM1032931,human lung cancer sample 922-T2,GSM1032931,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 76.8,survival status: A,age at surgery: 45.8,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),922-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032931/suppl/GSM1032931_5058818046_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032931/suppl/GSM1032931_5058818046_A_2.txt.gz,48803,45.8,IA,F,FALSE,Adenocarcinoma,76.8,A
GSM1032932,human lung cancer sample 952-T,GSM1032932,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 40.8,survival status: D,age at surgery: 61.1,gender: F,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),952-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032932/suppl/GSM1032932_5059335030_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032932/suppl/GSM1032932_5059335030_C_2.txt.gz,48803,61.1,IIA,F,FALSE,Adenocarcinoma,40.8,D
GSM1032935,human lung cancer sample 999-T,GSM1032935,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 61.2,survival status: D,age at surgery: 60.6,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),999-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032935/suppl/GSM1032935_5058818006_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032935/suppl/GSM1032935_5058818006_B_2.txt.gz,48803,60.6,IB,F,FALSE,Adenocarcinoma,61.2,D
GSM1032937,human lung cancer sample 1038-T2,GSM1032937,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 4.8,survival status: D,age at surgery: 68.6,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1038-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032937/suppl/GSM1032937_5059335018_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032937/suppl/GSM1032937_5059335018_A_2.txt.gz,48803,68.6,IIB,M,FALSE,Adenocarcinoma,4.8,D
GSM1032938,human lung cancer sample 1041-T,GSM1032938,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 73.2,survival status: D,age at surgery: 51.1,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1041-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032938/suppl/GSM1032938_5067386011_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032938/suppl/GSM1032938_5067386011_C_2.txt.gz,48803,51.1,IB,F,FALSE,Adenocarcinoma,73.2,D
GSM1032939,human lung cancer sample 1064-T,GSM1032939,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 55.2,survival status: D,age at surgery: 61.2,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1064-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032939/suppl/GSM1032939_5059335030_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032939/suppl/GSM1032939_5059335030_D_2.txt.gz,48803,61.2,IA,F,FALSE,Adenocarcinoma,55.2,D
GSM1032940,human lung cancer sample 1079-T,GSM1032940,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 27.6,survival status: D,age at surgery: 62.7,gender: M,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1079-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032940/suppl/GSM1032940_5067386015_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032940/suppl/GSM1032940_5067386015_C_2.txt.gz,48803,62.7,IIA,M,FALSE,Adenocarcinoma,27.6,D
GSM1032944,human lung cancer sample 1161-T,GSM1032944,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 82.8,survival status: A,age at surgery: 72.3,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1161-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032944/suppl/GSM1032944_5067386003_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032944/suppl/GSM1032944_5067386003_D_2.txt.gz,48803,72.3,IIIB,M,TRUE,Adenocarcinoma,82.8,A
GSM1032945,human lung cancer sample 1168-T,GSM1032945,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 72,survival status: A,age at surgery: 74.4,gender: M,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1168-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032945/suppl/GSM1032945_5067386026_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032945/suppl/GSM1032945_5067386026_F_2.txt.gz,48803,74.4,IIA,M,FALSE,Adenocarcinoma,72,A
GSM1032946,human lung cancer sample 1183-T,GSM1032946,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 66,survival status: A,age at surgery: 65.2,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1183-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032946/suppl/GSM1032946_5059335030_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032946/suppl/GSM1032946_5059335030_F_2.txt.gz,48803,65.2,IA,M,FALSE,Adenocarcinoma,66,A
GSM1032948,human lung cancer sample 1237-T,GSM1032948,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 51.6,survival status: D,age at surgery: 65.0,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1237-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032948/suppl/GSM1032948_5067386011_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032948/suppl/GSM1032948_5067386011_A_2.txt.gz,48803,65,IB,F,FALSE,Adenocarcinoma,51.6,D
GSM1032949,human lung cancer sample 1240-T,GSM1032949,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 76.8,survival status: A,age at surgery: 76.0,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1240-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032949/suppl/GSM1032949_5058818006_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032949/suppl/GSM1032949_5058818006_D_2.txt.gz,48803,76,IB,M,FALSE,Adenocarcinoma,76.8,A
GSM1032950,human lung cancer sample 1265-T,GSM1032950,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 66,survival status: A,age at surgery: 69.0,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1265-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032950/suppl/GSM1032950_5067319016_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032950/suppl/GSM1032950_5067319016_A_2.txt.gz,48803,69,IA,M,FALSE,Adenocarcinoma,66,A
GSM1032951,human lung cancer sample 1266-T,GSM1032951,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 26.4,survival status: D,age at surgery: 77.0,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1266-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032951/suppl/GSM1032951_5067386016_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032951/suppl/GSM1032951_5067386016_D_2.txt.gz,48803,77,IB,F,FALSE,Adenocarcinoma,26.4,D
GSM1032952,human lung cancer sample 1282-T,GSM1032952,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 64.8,survival status: A,age at surgery: 48.2,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1282-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032952/suppl/GSM1032952_5067319016_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032952/suppl/GSM1032952_5067319016_C_2.txt.gz,48803,48.2,IA,F,FALSE,Adenocarcinoma,64.8,A
GSM1032953,human lung cancer sample 1289-T,GSM1032953,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 74.4,survival status: A,age at surgery: 71.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1289-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032953/suppl/GSM1032953_5067386022_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032953/suppl/GSM1032953_5067386022_B_2.txt.gz,48803,71.3,IB,F,FALSE,Adenocarcinoma,74.4,A
GSM1032954,human lung cancer sample 1303-T,GSM1032954,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 64.8,survival status: A,age at surgery: 75.0,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1303-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032954/suppl/GSM1032954_5058818006_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032954/suppl/GSM1032954_5058818006_C_2.txt.gz,48803,75,IB,M,TRUE,Adenocarcinoma,64.8,A
GSM1032955,human lung cancer sample 1305-T,GSM1032955,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 60,survival status: A,age at surgery: 48.7,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1305-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032955/suppl/GSM1032955_5058818043_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032955/suppl/GSM1032955_5058818043_A_2.txt.gz,48803,48.7,IIIB,M,TRUE,Adenocarcinoma,60,A
GSM1032956,human lung cancer sample 1309-T,GSM1032956,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 69.6,survival status: A,age at surgery: 71.1,gender: F,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1309-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032956/suppl/GSM1032956_5059335021_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032956/suppl/GSM1032956_5059335021_E_2.txt.gz,48803,71.1,IIB,F,FALSE,Adenocarcinoma,69.6,A
GSM1032957,human lung cancer sample 1311-T,GSM1032957,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 68.4,survival status: A,age at surgery: 72.2,gender: F,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1311-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032957/suppl/GSM1032957_5051018084_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032957/suppl/GSM1032957_5051018084_C_2.txt.gz,48803,72.2,IIIB,F,FALSE,Adenocarcinoma,68.4,A
GSM1032958,human lung cancer sample 1323-T,GSM1032958,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 72,survival status: A,age at surgery: 67.2,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1323-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032958/suppl/GSM1032958_5058818005_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032958/suppl/GSM1032958_5058818005_B_2.txt.gz,48803,67.2,IB,F,TRUE,Adenocarcinoma,72,A
GSM1032959,human lung cancer sample 1325-T,GSM1032959,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 72,survival status: A,age at surgery: 74.8,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1325-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032959/suppl/GSM1032959_5059335028_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032959/suppl/GSM1032959_5059335028_B_2.txt.gz,48803,74.8,IIIB,M,TRUE,Adenocarcinoma,72,A
GSM1032961,human lung cancer sample 1332-T,GSM1032961,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 15.6,survival status: D,age at surgery: 47.6,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1332-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032961/suppl/GSM1032961_5067386026_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032961/suppl/GSM1032961_5067386026_A_2.txt.gz,48803,47.6,IIB,M,FALSE,Adenocarcinoma,15.6,D
GSM1032962,human lung cancer sample 1353-T,GSM1032962,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 63.6,survival status: A,age at surgery: 60.0,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1353-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032962/suppl/GSM1032962_5067386013_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032962/suppl/GSM1032962_5067386013_D_2.txt.gz,48803,60,IB,F,TRUE,Adenocarcinoma,63.6,A
GSM1032963,human lung cancer sample 1355-T,GSM1032963,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 62.4,survival status: A,age at surgery: 57.9,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1355-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032963/suppl/GSM1032963_5067386013_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032963/suppl/GSM1032963_5067386013_C_2.txt.gz,48803,57.9,IB,F,TRUE,Adenocarcinoma,62.4,A
GSM1032964,human lung cancer sample 1357-T,GSM1032964,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 48,survival status: A,age at surgery: 70.2,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1357-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032964/suppl/GSM1032964_5067319016_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032964/suppl/GSM1032964_5067319016_D_2.txt.gz,48803,70.2,IA,F,FALSE,Adenocarcinoma,48,A
GSM1032968,human lung cancer sample 1376-T,GSM1032968,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 70.8,survival status: A,age at surgery: 63.8,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1376-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032968/suppl/GSM1032968_5058818040_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032968/suppl/GSM1032968_5058818040_E_2.txt.gz,48803,63.8,IIB,M,FALSE,Adenocarcinoma,70.8,A
GSM1032969,human lung cancer sample 1378-T,GSM1032969,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 69.6,survival status: A,age at surgery: 66.3,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1378-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032969/suppl/GSM1032969_5067319016_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032969/suppl/GSM1032969_5067319016_F_2.txt.gz,48803,66.3,IA,F,FALSE,Adenocarcinoma,69.6,A
GSM1032970,human lung cancer sample 1380-T,GSM1032970,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 70.8,survival status: A,age at surgery: 73.7,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1380-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032970/suppl/GSM1032970_5067386010_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032970/suppl/GSM1032970_5067386010_E_2.txt.gz,48803,73.7,IB,F,TRUE,Adenocarcinoma,70.8,A
GSM1032973,human lung cancer sample 1416-T,GSM1032973,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 49.2,survival status: A,age at surgery: 63.0,gender: F,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1416-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032973/suppl/GSM1032973_5059335021_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032973/suppl/GSM1032973_5059335021_D_2.txt.gz,48803,63,IIB,F,TRUE,Adenocarcinoma,49.2,A
GSM1032975,human lung cancer sample 1443-T,GSM1032975,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 60,survival status: A,age at surgery: 73.4,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1443-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032975/suppl/GSM1032975_5067386016_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032975/suppl/GSM1032975_5067386016_E_2.txt.gz,48803,73.4,IB,F,FALSE,Adenocarcinoma,60,A
GSM1032976,human lung cancer sample 1462-T,GSM1032976,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 64.8,survival status: A,age at surgery: 79.4,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1462-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032976/suppl/GSM1032976_5067386006_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032976/suppl/GSM1032976_5067386006_C_2.txt.gz,48803,79.4,IIB,M,FALSE,Adenocarcinoma,64.8,A
GSM1032977,human lung cancer sample 1465-T,GSM1032977,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 68.4,survival status: A,age at surgery: 68.2,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1465-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032977/suppl/GSM1032977_5058746016_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032977/suppl/GSM1032977_5058746016_B_2.txt.gz,48803,68.2,IB,F,FALSE,Adenocarcinoma,68.4,A
GSM1032978,human lung cancer sample 1476-T,GSM1032978,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 62.4,survival status: A,age at surgery: 67.9,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1476-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032978/suppl/GSM1032978_5058746016_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032978/suppl/GSM1032978_5058746016_C_2.txt.gz,48803,67.9,IB,F,FALSE,Adenocarcinoma,62.4,A
GSM1032980,human lung cancer sample 1496-T,GSM1032980,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 62.4,survival status: A,age at surgery: 65.7,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1496-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032980/suppl/GSM1032980_5067386011_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032980/suppl/GSM1032980_5067386011_D_2.txt.gz,48803,65.7,IB,F,TRUE,Adenocarcinoma,62.4,A
GSM1032981,human lung cancer sample 1498-T,GSM1032981,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 34.8,survival status: D,age at surgery: 81.5,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1498-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032981/suppl/GSM1032981_5067386013_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032981/suppl/GSM1032981_5067386013_F_2.txt.gz,48803,81.5,IB,F,FALSE,Adenocarcinoma,34.8,D
GSM1032982,human lung cancer sample 1502-T2,GSM1032982,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 40.8,survival status: D,age at surgery: 81.6,gender: M,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1502-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032982/suppl/GSM1032982_5067386026_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032982/suppl/GSM1032982_5067386026_C_2.txt.gz,48803,81.6,IIA,M,FALSE,Adenocarcinoma,40.8,D
GSM1032983,human lung cancer sample 1510-Tx,GSM1032983,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 64.8,survival status: A,age at surgery: 58.1,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1510-Tx,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032983/suppl/GSM1032983_5059335014_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032983/suppl/GSM1032983_5059335014_C_2.txt.gz,48803,58.1,IB,M,TRUE,Adenocarcinoma,64.8,A
GSM1032984,human lung cancer sample 1549-T,GSM1032984,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 45.6,survival status: A,age at surgery: 42.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1549-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032984/suppl/GSM1032984_5067386022_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032984/suppl/GSM1032984_5067386022_A_2.txt.gz,48803,42.3,IB,F,TRUE,Adenocarcinoma,45.6,A
GSM1032985,human lung cancer sample 1551-T,GSM1032985,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 61.2,survival status: A,age at surgery: 75.5,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1551-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032985/suppl/GSM1032985_5059335028_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032985/suppl/GSM1032985_5059335028_A_2.txt.gz,48803,75.5,IA,F,FALSE,Adenocarcinoma,61.2,A
GSM1032987,human lung cancer sample 1601-T,GSM1032987,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 56.4,survival status: A,age at surgery: 81.7,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1601-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032987/suppl/GSM1032987_5059335028_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032987/suppl/GSM1032987_5059335028_E_2.txt.gz,48803,81.7,IB,M,TRUE,Adenocarcinoma,56.4,A
GSM1032988,human lung cancer sample 1607-T,GSM1032988,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 49.2,survival status: D,age at surgery: 57.6,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1607-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032988/suppl/GSM1032988_5067319018_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032988/suppl/GSM1032988_5067319018_C_2.txt.gz,48803,57.6,IIB,M,TRUE,Adenocarcinoma,49.2,D
GSM1032990,human lung cancer sample 1662-T,GSM1032990,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 58.8,survival status: A,age at surgery: 57.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1662-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032990/suppl/GSM1032990_5051018065_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032990/suppl/GSM1032990_5051018065_E_2.txt.gz,48803,57.3,IB,F,TRUE,Adenocarcinoma,58.8,A
GSM1032991,human lung cancer sample 1671-T,GSM1032991,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 51.6,survival status: A,age at surgery: 61.5,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1671-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032991/suppl/GSM1032991_5067386003_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032991/suppl/GSM1032991_5067386003_C_2.txt.gz,48803,61.5,IIIB,M,TRUE,Adenocarcinoma,51.6,A
GSM1032993,human lung cancer sample 1714-T,GSM1032993,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 28.8,survival status: D,age at surgery: 65.4,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1714-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032993/suppl/GSM1032993_5067386006_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032993/suppl/GSM1032993_5067386006_B_2.txt.gz,48803,65.4,IIB,M,TRUE,Adenocarcinoma,28.8,D
GSM1032994,human lung cancer sample 1718-T,GSM1032994,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 58.8,survival status: A,age at surgery: 60.3,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1718-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032994/suppl/GSM1032994_5059335013_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032994/suppl/GSM1032994_5059335013_A_2.txt.gz,48803,60.3,IB,M,TRUE,Adenocarcinoma,58.8,A
GSM1032995,human lung cancer sample 1723-T,GSM1032995,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 39.6,survival status: A,age at surgery: 56.4,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1723-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032995/suppl/GSM1032995_5058818006_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032995/suppl/GSM1032995_5058818006_F_2.txt.gz,48803,56.4,IA,F,TRUE,Adenocarcinoma,39.6,A
GSM1032996,human lung cancer sample 1727-T,GSM1032996,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 50.4,survival status: A,age at surgery: 58.3,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1727-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032996/suppl/GSM1032996_5067386016_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032996/suppl/GSM1032996_5067386016_F_2.txt.gz,48803,58.3,IA,M,FALSE,Adenocarcinoma,50.4,A
GSM1032997,human lung cancer sample 1729-T,GSM1032997,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 43.2,survival status: A,age at surgery: 74.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1729-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032997/suppl/GSM1032997_5067386002_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032997/suppl/GSM1032997_5067386002_C_2.txt.gz,48803,74.3,IB,F,TRUE,Adenocarcinoma,43.2,A
GSM1032998,human lung cancer sample 1761-T,GSM1032998,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 52.8,survival status: A,age at surgery: 75.0,gender: M,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1761-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032998/suppl/GSM1032998_5051026018_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032998/suppl/GSM1032998_5051026018_C_2.txt.gz,48803,75,IIIA,M,TRUE,Adenocarcinoma,52.8,A
GSM1032999,human lung cancer sample 1804-T,GSM1032999,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 39.6,survival status: D,age at surgery: 44.3,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1804-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032999/suppl/GSM1032999_5058818005_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1032nnn/GSM1032999/suppl/GSM1032999_5058818005_D_2.txt.gz,48803,44.3,IB,M,TRUE,Adenocarcinoma,39.6,D
GSM1033000,human lung cancer sample 1805-T,GSM1033000,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 45.6,survival status: A,age at surgery: 57.7,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1805-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033000/suppl/GSM1033000_5067386029_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033000/suppl/GSM1033000_5067386029_B_2.txt.gz,48803,57.7,IB,M,TRUE,Adenocarcinoma,45.6,A
GSM1033001,human lung cancer sample 1809-T,GSM1033001,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 22.8,survival status: D,age at surgery: 78.5,gender: M,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1809-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033001/suppl/GSM1033001_5058818049_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033001/suppl/GSM1033001_5058818049_B_2.txt.gz,48803,78.5,IIIA,M,TRUE,Adenocarcinoma,22.8,D
GSM1033003,human lung cancer sample 1833-T,GSM1033003,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 8.4,survival status: D,age at surgery: 80.0,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1833-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033003/suppl/GSM1033003_5058818005_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033003/suppl/GSM1033003_5058818005_E_2.txt.gz,48803,80,IB,M,FALSE,Adenocarcinoma,8.4,D
GSM1033004,human lung cancer sample 1834-T,GSM1033004,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 0,survival status: D,age at surgery: 74.6,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1834-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033004/suppl/GSM1033004_5067319052_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033004/suppl/GSM1033004_5067319052_C_2.txt.gz,48803,74.6,IB,M,FALSE,Adenocarcinoma,0,D
GSM1033005,human lung cancer sample 1839-T,GSM1033005,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 52.8,survival status: A,age at surgery: 77.1,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1839-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033005/suppl/GSM1033005_5067386029_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033005/suppl/GSM1033005_5067386029_D_2.txt.gz,48803,77.1,IB,M,TRUE,Adenocarcinoma,52.8,A
GSM1033006,human lung cancer sample 1853-T,GSM1033006,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 33.6,survival status: D,age at surgery: 71.3,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1853-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033006/suppl/GSM1033006_5067386002_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033006/suppl/GSM1033006_5067386002_E_2.txt.gz,48803,71.3,IIIB,M,TRUE,Adenocarcinoma,33.6,D
GSM1033007,human lung cancer sample 1858-T2,GSM1033007,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 50.4,survival status: A,age at surgery: 75.1,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1858-T2,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033007/suppl/GSM1033007_5058746016_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033007/suppl/GSM1033007_5058746016_F_2.txt.gz,48803,75.1,IA,F,FALSE,Adenocarcinoma,50.4,A
GSM1033008,human lung cancer sample 1867-T,GSM1033008,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 38.4,survival status: A,age at surgery: 73.4,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1867-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033008/suppl/GSM1033008_5058818010_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033008/suppl/GSM1033008_5058818010_A_2.txt.gz,48803,73.4,IA,M,FALSE,Adenocarcinoma,38.4,A
GSM1033010,human lung cancer sample 1888-T,GSM1033010,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 12,survival status: D,age at surgery: 60.9,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1888-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033010/suppl/GSM1033010_5067319052_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033010/suppl/GSM1033010_5067319052_B_2.txt.gz,48803,60.9,IIB,M,TRUE,Adenocarcinoma,12,D
GSM1033011,human lung cancer sample 1894-T,GSM1033011,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 14.4,survival status: D,age at surgery: 76.1,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1894-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033011/suppl/GSM1033011_5058818010_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033011/suppl/GSM1033011_5058818010_B_2.txt.gz,48803,76.1,IA,M,FALSE,Adenocarcinoma,14.4,D
GSM1033012,human lung cancer sample 1898-T,GSM1033012,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 16.8,survival status: A,age at surgery: 75.7,gender: F,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1898-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033012/suppl/GSM1033012_5058818043_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033012/suppl/GSM1033012_5058818043_D_2.txt.gz,48803,75.7,IIIB,F,TRUE,Adenocarcinoma,16.8,A
GSM1033013,human lung cancer sample 1908-T,GSM1033013,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 43.2,survival status: A,age at surgery: 62.7,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1908-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033013/suppl/GSM1033013_5067319052_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033013/suppl/GSM1033013_5067319052_E_2.txt.gz,48803,62.7,IB,F,FALSE,Adenocarcinoma,43.2,A
GSM1033014,human lung cancer sample 1911-T,GSM1033014,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 50.4,survival status: A,age at surgery: 63.1,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1911-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033014/suppl/GSM1033014_5058818010_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033014/suppl/GSM1033014_5058818010_C_2.txt.gz,48803,63.1,IA,M,FALSE,Adenocarcinoma,50.4,A
GSM1033015,human lung cancer sample 1913-T,GSM1033015,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 31.2,survival status: A,age at surgery: 60.7,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1913-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033015/suppl/GSM1033015_5058818010_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033015/suppl/GSM1033015_5058818010_D_2.txt.gz,48803,60.7,IA,F,FALSE,Adenocarcinoma,31.2,A
GSM1033016,human lung cancer sample 1921-T,GSM1033016,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 38.4,survival status: A,age at surgery: 64.5,gender: M,final.pat.stage: IIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1921-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033016/suppl/GSM1033016_5067386026_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033016/suppl/GSM1033016_5067386026_E_2.txt.gz,48803,64.5,IIA,M,TRUE,Adenocarcinoma,38.4,A
GSM1033017,human lung cancer sample 1930-T,GSM1033017,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 50.4,survival status: A,age at surgery: 66.6,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1930-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033017/suppl/GSM1033017_5059335028_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033017/suppl/GSM1033017_5059335028_F_2.txt.gz,48803,66.6,IA,M,FALSE,Adenocarcinoma,50.4,A
GSM1033018,human lung cancer sample 1933-T,GSM1033018,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 36,survival status: A,age at surgery: 55.3,gender: F,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1933-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033018/suppl/GSM1033018_5067386013_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033018/suppl/GSM1033018_5067386013_B_2.txt.gz,48803,55.3,IIIA,F,TRUE,Adenocarcinoma,36,A
GSM1033019,human lung cancer sample 1936-T,GSM1033019,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 4.8,survival status: D,age at surgery: 81.5,gender: M,final.pat.stage: IV,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1936-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033019/suppl/GSM1033019_5058818043_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033019/suppl/GSM1033019_5058818043_B_2.txt.gz,48803,81.5,IV,M,FALSE,Adenocarcinoma,4.8,D
GSM1033020,human lung cancer sample 1944-T,GSM1033020,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 49.2,survival status: A,age at surgery: 76.5,gender: F,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1944-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033020/suppl/GSM1033020_5058818046_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033020/suppl/GSM1033020_5058818046_C_2.txt.gz,48803,76.5,IIIB,F,FALSE,Adenocarcinoma,49.2,A
GSM1033021,human lung cancer sample 1956-T,GSM1033021,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 34.8,survival status: A,age at surgery: 50.2,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1956-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033021/suppl/GSM1033021_5058818010_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033021/suppl/GSM1033021_5058818010_E_2.txt.gz,48803,50.2,IB,F,FALSE,Adenocarcinoma,34.8,A
GSM1033022,human lung cancer sample 1964-T,GSM1033022,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 45.6,survival status: A,age at surgery: 53.6,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1964-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033022/suppl/GSM1033022_5067386002_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033022/suppl/GSM1033022_5067386002_F_2.txt.gz,48803,53.6,IB,M,FALSE,Adenocarcinoma,45.6,A
GSM1033023,human lung cancer sample 1966-T,GSM1033023,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 24,survival status: A,age at surgery: 66.0,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1966-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033023/suppl/GSM1033023_5058818010_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033023/suppl/GSM1033023_5058818010_F_2.txt.gz,48803,66,IA,M,FALSE,Adenocarcinoma,24,A
GSM1033024,human lung cancer sample 1972-T,GSM1033024,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 48,survival status: A,age at surgery: 68.9,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),1972-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033024/suppl/GSM1033024_5067386003_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033024/suppl/GSM1033024_5067386003_E_2.txt.gz,48803,68.9,IA,F,FALSE,Adenocarcinoma,48,A
GSM1033025,human lung cancer sample 2024-T,GSM1033025,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 43.2,survival status: A,age at surgery: 61.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2024-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033025/suppl/GSM1033025_5067386002_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033025/suppl/GSM1033025_5067386002_B_2.txt.gz,48803,61.3,IB,F,TRUE,Adenocarcinoma,43.2,A
GSM1033029,human lung cancer sample 2078-T,GSM1033029,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 38.4,survival status: A,age at surgery: 72.3,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2078-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033029/suppl/GSM1033029_5067319018_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033029/suppl/GSM1033029_5067319018_F_2.txt.gz,48803,72.3,IB,M,TRUE,Adenocarcinoma,38.4,A
GSM1033030,human lung cancer sample 2135-T,GSM1033030,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 24,survival status: A,age at surgery: 60.1,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2135-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033030/suppl/GSM1033030_5067386014_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033030/suppl/GSM1033030_5067386014_F_2.txt.gz,48803,60.1,IIIB,M,TRUE,Adenocarcinoma,24,A
GSM1033031,human lung cancer sample 2155-T,GSM1033031,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 27.6,survival status: D,age at surgery: 59.4,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2155-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033031/suppl/GSM1033031_5058818006_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033031/suppl/GSM1033031_5058818006_A_2.txt.gz,48803,59.4,IB,F,TRUE,Adenocarcinoma,27.6,D
GSM1033032,human lung cancer sample 2172-T,GSM1033032,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 32.4,survival status: A,age at surgery: 68.3,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2172-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033032/suppl/GSM1033032_5067386003_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033032/suppl/GSM1033032_5067386003_F_2.txt.gz,48803,68.3,IA,M,FALSE,Adenocarcinoma,32.4,A
GSM1033034,human lung cancer sample 2190-T,GSM1033034,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 20.4,survival status: A,age at surgery: 81.9,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2190-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033034/suppl/GSM1033034_5058818011_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033034/suppl/GSM1033034_5058818011_C_2.txt.gz,48803,81.9,IA,F,FALSE,Adenocarcinoma,20.4,A
GSM1033035,human lung cancer sample 2192-T,GSM1033035,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 30,survival status: A,age at surgery: 74.3,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2192-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033035/suppl/GSM1033035_5059335013_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033035/suppl/GSM1033035_5059335013_D_2.txt.gz,48803,74.3,IB,M,FALSE,Adenocarcinoma,30,A
GSM1033036,human lung cancer sample 2204-T,GSM1033036,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 20.4,survival status: A,age at surgery: 77.2,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2204-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033036/suppl/GSM1033036_5059335009_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033036/suppl/GSM1033036_5059335009_B_2.txt.gz,48803,77.2,IB,M,TRUE,Adenocarcinoma,20.4,A
GSM1033037,human lung cancer sample 2207-T,GSM1033037,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 28.8,survival status: A,age at surgery: 73.1,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2207-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033037/suppl/GSM1033037_5067319018_B_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033037/suppl/GSM1033037_5067319018_B_2.txt.gz,48803,73.1,IB,F,FALSE,Adenocarcinoma,28.8,A
GSM1033038,human lung cancer sample 2212-T,GSM1033038,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 28.8,survival status: A,age at surgery: 52.6,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2212-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033038/suppl/GSM1033038_5067319018_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033038/suppl/GSM1033038_5067319018_A_2.txt.gz,48803,52.6,IB,F,TRUE,Adenocarcinoma,28.8,A
GSM1033039,human lung cancer sample 2230-T,GSM1033039,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 2.4,survival status: A,age at surgery: 48.1,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2230-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033039/suppl/GSM1033039_5067319052_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033039/suppl/GSM1033039_5067319052_F_2.txt.gz,48803,48.1,IB,F,FALSE,Adenocarcinoma,2.4,A
GSM1033040,human lung cancer sample 2247-T,GSM1033040,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 18,survival status: D,age at surgery: 80.3,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2247-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033040/suppl/GSM1033040_5059335015_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033040/suppl/GSM1033040_5059335015_C_2.txt.gz,48803,80.3,IIIB,M,FALSE,Adenocarcinoma,18,D
GSM1033041,human lung cancer sample 2249-T,GSM1033041,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 13.2,survival status: A,age at surgery: 55.4,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2249-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033041/suppl/GSM1033041_5058818011_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033041/suppl/GSM1033041_5058818011_D_2.txt.gz,48803,55.4,IA,F,FALSE,Adenocarcinoma,13.2,A
GSM1033043,human lung cancer sample 2264-T,GSM1033043,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 25.2,survival status: A,age at surgery: 71.4,gender: M,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2264-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033043/suppl/GSM1033043_5058818004_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033043/suppl/GSM1033043_5058818004_F_2.txt.gz,48803,71.4,IB,M,FALSE,Adenocarcinoma,25.2,A
GSM1033044,human lung cancer sample 2274-T,GSM1033044,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 22.8,survival status: D,age at surgery: 64.6,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2274-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033044/suppl/GSM1033044_5058818011_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033044/suppl/GSM1033044_5058818011_E_2.txt.gz,48803,64.6,IA,F,FALSE,Adenocarcinoma,22.8,D
GSM1033045,human lung cancer sample 2275-T,GSM1033045,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 25.2,survival status: A,age at surgery: 55.5,gender: M,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2275-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033045/suppl/GSM1033045_5058818011_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033045/suppl/GSM1033045_5058818011_F_2.txt.gz,48803,55.5,IA,M,FALSE,Adenocarcinoma,25.2,A
GSM1033046,human lung cancer sample 2279-T,GSM1033046,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 24,survival status: A,age at surgery: 81.8,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2279-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033046/suppl/GSM1033046_5058818022_A_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033046/suppl/GSM1033046_5058818022_A_2.txt.gz,48803,81.8,IA,F,FALSE,Adenocarcinoma,24,A
GSM1033047,human lung cancer sample 2281-T,GSM1033047,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 14.4,survival status: A,age at surgery: 86.2,gender: F,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2281-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033047/suppl/GSM1033047_5058818040_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033047/suppl/GSM1033047_5058818040_C_2.txt.gz,48803,86.2,IIIB,F,FALSE,Adenocarcinoma,14.4,A
GSM1033049,human lung cancer sample 2293-T,GSM1033049,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 14.4,survival status: D,age at surgery: 82.1,gender: M,final.pat.stage: IIIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2293-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033049/suppl/GSM1033049_5059335013_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033049/suppl/GSM1033049_5059335013_C_2.txt.gz,48803,82.1,IIIB,M,TRUE,Adenocarcinoma,14.4,D
GSM1033050,human lung cancer sample 2296-T,GSM1033050,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 20.4,survival status: A,age at surgery: 50.3,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2296-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033050/suppl/GSM1033050_5058818022_C_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033050/suppl/GSM1033050_5058818022_C_2.txt.gz,48803,50.3,IA,F,FALSE,Adenocarcinoma,20.4,A
GSM1033051,human lung cancer sample 2299-T,GSM1033051,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 14.4,survival status: A,age at surgery: 72.2,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2299-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033051/suppl/GSM1033051_5058818022_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033051/suppl/GSM1033051_5058818022_D_2.txt.gz,48803,72.2,IA,F,FALSE,Adenocarcinoma,14.4,A
GSM1033052,human lung cancer sample 2305-T,GSM1033052,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 1.2,survival status: A,age at surgery: 82.1,gender: M,final.pat.stage: IIIA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2305-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033052/suppl/GSM1033052_5051026018_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033052/suppl/GSM1033052_5051026018_D_2.txt.gz,48803,82.1,IIIA,M,FALSE,Adenocarcinoma,1.2,A
GSM1033053,human lung cancer sample 2308-T,GSM1033053,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 4.8,survival status: A,age at surgery: 44.2,gender: M,final.pat.stage: IIB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2308-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033053/suppl/GSM1033053_5059335016_F_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033053/suppl/GSM1033053_5059335016_F_2.txt.gz,48803,44.2,IIB,M,TRUE,Adenocarcinoma,4.8,A
GSM1033054,human lung cancer sample 2311-T,GSM1033054,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 19.2,survival status: A,age at surgery: 66.3,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2311-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033054/suppl/GSM1033054_5067386006_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033054/suppl/GSM1033054_5067386006_E_2.txt.gz,48803,66.3,IB,F,FALSE,Adenocarcinoma,19.2,A
GSM1033055,human lung cancer sample 2313-T,GSM1033055,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: FALSE,overall survival months: 18,survival status: A,age at surgery: 51.2,gender: F,final.pat.stage: IA,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2313-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033055/suppl/GSM1033055_5058818022_E_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033055/suppl/GSM1033055_5058818022_E_2.txt.gz,48803,51.2,IA,F,FALSE,Adenocarcinoma,18,A
GSM1033056,human lung cancer sample 2319-T,GSM1033056,Public on Jan 30 2013,Nov 07 2012,Jan 30 2013,RNA,1,Non-Small-Cell Lung Cancer,Homo sapiens,had_adjuvant_chemo: TRUE,overall survival months: 20.4,survival status: A,age at surgery: 59.8,gender: F,final.pat.stage: IB,histology: Adenocarcinoma,total RNA,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),biotin,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),9606,According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),According to the Illumina standard protocol. (Illumina HumanWG-6 v3 Array),2319-T,Microarray data analysis and quality control were based on the Model-Based Background Correction (MBCB) method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874975/,GPL6884,"Hao,,Tang",hao.tang@utsouthwestern.edu,2146484210,QBRC,Clinical Sciences,UT Southwestern Medical Center,5323 Harry Hines Blvd,Dallas,Texas,75390,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033056/suppl/GSM1033056_5067386006_D_1.txt.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1033nnn/GSM1033056/suppl/GSM1033056_5067386006_D_2.txt.gz,48803,59.8,IB,F,TRUE,Adenocarcinoma,20.4,A
